-
Encofenib Encofenib is indicated in combination with bimetinib for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation as detected by an FDA-approved test.
Regular price ¥8,000.00 CNYRegular priceUnit price per¥14,000.00 CNYSale price ¥8,000.00 CNYSale -
Conafenib, BRATODX, Encorafenib
Regular price ¥4,600.00 CNYRegular priceUnit price per¥7,000.00 CNYSale price ¥4,600.00 CNYSale -
Trametinib, TRAMEDX, Trametinib 2mg
Regular price ¥1,200.00 CNYRegular priceUnit price per¥1,800.00 CNYSale price ¥1,200.00 CNYSale -
Trametinib is indicated as a single agent or in combination with dabrafenib for the treatment of patients with unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations.
Regular price ¥900.00 CNYRegular priceUnit price per¥1,700.00 CNYSale price ¥900.00 CNYSale -
TRAMAKS 2 Trametinib 2mg 30s
Regular price ¥900.00 CNYRegular priceUnit price per¥1,500.00 CNYSale price ¥900.00 CNYSale
